Ellodi
Blue Bell, United States · Founded 2020
- Headquarters
- Blue Bell
- Founded
- 2020
- Business Model
- B2B
- Website
- ellodipharma.com
- Last Round
- Corporate RoundOct 2020
- Rounds
- 1
About
Ellodi Pharmaceuticals is a gastroenterology-focused specialty pharmaceutical company developing novel therapies for the treatment of Eosinophilic Esophagitis (EoE). Formed in 2020 when TPG Capital created Ellodi to continue clinical development of APT-1011, the company is advancing its pipeline through studies including the FLUTE 3 Study to bring new treatment options to EoE patients.
Summary
Ellodi is a Biotech company based in Blue Bell, United States, founded in 2020. Its most recent funding was a Corporate Round round in Oct 2020. Investors include TPG (Growth/Rise).
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2020
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...